Trails Edge Capital Partners’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
Trails Edge Capital Partners's OBX Position: Q3 2026 in Review
Trails Edge Capital Partners opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 2,495,660 shares worth $34.3M. The stake represents 4.92% of the portfolio and ranks #4 among its holdings.
61 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- Trails Edge Capital Partners held 2,495,660 shares of Obsidian Therapeutics worth $34.3M as of Q3 2026.
- Obsidian Therapeutics was a new Trails Edge Capital Partners position in Q3 2026.
- Obsidian Therapeutics made up 4.92% of Trails Edge Capital Partners's portfolio in Q3 2026, its #4 holding.
- 61 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on Trails Edge Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.